US 9839685
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
granted A61KA61K2039/541A61K2039/543
Quick answer
US patent 9839685 (Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/541, A61K2039/543, A61K2039/55555, A61K2039/55561